Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Non-Current Deferred Tax Liability (2016 - 2018)

Apyx Medical's Non-Current Deferred Tax Liability history spans 7 years, with the latest figure at $368000.0 for Q2 2018.

  • For Q2 2018, Non-Current Deferred Tax Liability fell 34.75% year-over-year to $368000.0; the TTM value through Jun 2018 reached $368000.0, down 34.75%, while the annual FY2017 figure was $368000.0, 34.75% down from the prior year.
  • Non-Current Deferred Tax Liability reached $368000.0 in Q2 2018 per APYX's latest filing, roughly flat from $368000.0 in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $564000.0 in Q4 2015 to a low of $368000.0 in Q4 2017.
  • Average Non-Current Deferred Tax Liability over 4 years is $490500.0, with a median of $564000.0 recorded in 2015.
  • Peak YoY movement for Non-Current Deferred Tax Liability: changed 0.0% in 2016, then tumbled 34.75% in 2017.
  • A 4-year view of Non-Current Deferred Tax Liability shows it stood at $564000.0 in 2015, then changed by 0.0% to $564000.0 in 2016, then tumbled by 34.75% to $368000.0 in 2017, then changed by 0.0% to $368000.0 in 2018.
  • Per Business Quant, the three most recent readings for APYX's Non-Current Deferred Tax Liability are $368000.0 (Q2 2018), $368000.0 (Q1 2018), and $368000.0 (Q4 2017).